ARCUTIS BIOTHERAPEUTICS INC (ARQT)

US03969K1088 - Common Stock

8  -0.6 (-6.98%)

After market: 8.01 +0.01 (+0.12%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
59.61M3.69M0.000.000.00
Cost Of Goods
4.99M750.00KN/AN/AN/A
Gross Profit
54.62M2.93MN/AN/AN/A
Operating Expenses
295.72M304.56M206.53M136.65M43.13M
Research and Development
110.58M182.44M145.56M115.31M36.52M
Selling, General, and Administrative Expenses
185.15M122.12M60.97M21.34M6.61M
Operating Income
-241.10M-301.63M-206.53M-136.65M-43.13M
Interest Income/Expense
-29.71M-15.65MN/AN/AN/A
Other Income/Expense
11.79M5.82M170.00K970.00K1.14M
Income Before Taxes
-259.03M-311.46M-206.36M-135.68M-42.00M
Income Tax
3.11MN/AN/AN/AN/A
Net Income
-262.14M-311.46M-206.36M-135.68M-42.00M
EBITDA
-239.58M-300.70M-206.08M-136.53M-43.06M
 
Per Share Data
EPS Diluted Total Ops
-3.78-5.66-4.18-3.80-1.15
Non GAAP EPS
-3.92-5.65-4.16-3.89N/A
 
Statistics
Gross Profit Margin
91.63%79.40%N/AN/AN/A
Profit Margin
-439.79%-8440.65%N/AN/AN/A
Operating Profit Margin
-404.49%-8174.25%N/AN/AN/A

All data in USD

Charts